Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00911586Phase 2Completed
A Phase 2 trial of testosterone undecanoate in male hypogonadism, sponsored by Clarus Therapeutics. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00911586.